Published online before print May 22, 2006, doi: 10.1161/01.HYP.0000224296.96235.dd
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2006;48:127.)
© 2006 American Heart Association, Inc.
Original Articles |
11ß-Hydroxysteroid Dehydrogenase Type 2 Activity in Hypothalamic Paraventricular Nucleus Modulates Sympathetic Excitation
From the Departments of Internal Medicine (Z.-H.Z., Y.-M.K., Y.Y., S.-G.W., R.B.F.), Physiology and Biophysics (T.J.S.), and Psychology (A.K.J.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa, and Veterans Affairs Medical Center (R.B.F.), Iowa City, Iowa.
Correspondence to Robert B. Felder, MD, University of Iowa College of Medicine, E318-GH, 200 Hawkins Drive, Iowa City, IA 52242. E-mail robert-felder{at}uiowa.edu
Aldosterone stimulates the sympathetic nervous system by binding to a select population of brain mineralocorticoid receptors (MR). These MR have an equal affinity for corticosterone that is present in substantially higher concentrations, but are held in reserve for aldosterone by activity of the enzyme 11ß-hydroxysteroid dehydrogenase type 2 (11ß-HSD-2), which converts corticosterone to an inactive metabolite. Thus, colocalization of MR and 11ß-HSD-2 activity may help identify brain regions that mediate the effects of aldosterone. The present studies tested the hypothesis that 11ß-HSD-2 activity regulates MR-mediated responses in the paraventricular nucleus (PVN) of the hypothalamus, a forebrain region implicated in sympathetic regulation. Real-time–polymerase chain reaction revealed the presence of 11ß-HSD-2 mRNA in PVN. In anesthetized adult male Sprague-Dawley rats, microinjection of the 11ß-HSD-2 inhibitor carbenoxolone (CBX) into PVN increased mean arterial pressure, heart rate, and renal sympathetic nerve activity. Intracerebroventricular injections of CBX excited PVN neurons and increased mean arterial pressure, heart rate, and renal sympathetic nerve activity. The ability of CBX to increase sympathetic activity by inhibiting 11ß-HSD-2, thereby permitting corticosterone to activate MR, was confirmed by the following: Intracerebroventricular glycyrrhizic acid, another 11ß-HSD-2 inhibitor, mimicked the sympathoexcitatory effects of CBX; the sympathoexcitatory effects of CBX were blocked by spironolactone, a MR antagonist. Neither CBX nor glycyrrhizic acid elicited a response in adrenalectomized rats. These findings suggest that MR in PVN contribute to sympathetic regulation and may be activated by aldosterone or corticosterone (or cortisol in humans) depending on the state of 11ß-HSD-2 activity.
Key Words: aldosterone • corticosterone • brain
This article has been cited by other articles:
 |
|
 |
|
  J. C. Geerling and A. D. Loewy Aldosterone in the brain Am J Physiol Renal Physiol, September 1, 2009; 297(3): F559 - F576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Xue, D. Badaue-Passos Jr, F. Guo, C. E. Gomez-Sanchez, M. Hay, and A. K. Johnson Sex differences and central protective effect of 17{beta}-estradiol in the development of aldosterone/NaCl-induced hypertension Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1577 - H1585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Huang, R. A. White, A. Y. Jeng, and F. H. H. Leenen Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R994 - R1000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gabor and F. H. H. Leenen Mechanisms in the PVN mediating local and central sodium-induced hypertension in Wistar rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R618 - R630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Huang, R. A. White, M. Ahmad, J. Tan, A. Y. Jeng, and F. H.H. Leenen Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction Cardiovasc Res, February 15, 2009; 81(3): 574 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Huang, R. A. White, M. Ahmad, A. Y. Jeng, and F. H. H. Leenen Central infusion of aldosterone synthase inhibitor prevents sympathetic hyperactivity and hypertension by central Na+ in Wistar rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R166 - R172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yu, S.-G. Wei, Z.-H. Zhang, E. Gomez-Sanchez, R. M. Weiss, and R. B. Felder Does Aldosterone Upregulate the Brain Renin-Angiotensin System in Rats With Heart Failure? Hypertension, March 1, 2008; 51(3): 727 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Yang, L. H. Li, S. Y. Shin, S. Lee, S. Y. Lee, S. K. Han, and P. D. Ryu Adrenalectomy Potentiates Noradrenergic Suppression of GABAergic Transmission in Parvocellular Neurosecretory Neurons of Hypothalamic Paraventricular Nucleus J Neurophysiol, February 1, 2008; 99(2): 514 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-H. Zhang, Y. Yu, Y.-M. Kang, S.-G. Wei, and R. B. Felder Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H1067 - H1074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Marissal-Arvy, A. Gaumont, A. Langlois, F. Dabertrand, M. Bouchecareilh, C. Tridon, and P. Mormede Strain differences in hypothalamic pituitary adrenocortical axis function and adipogenic effects of corticosterone in rats J. Endocrinol., December 1, 2007; 195(3): 473 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fujita, K. Ando, A. Nagae, and T. Fujita Sympathoexcitation by Oxidative Stress in the Brain Mediates Arterial Pressure Elevation in Salt-Sensitive Hypertension Hypertension, August 1, 2007; 50(2): 360 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Naray-Fejes-Toth and G. Fejes-Toth Reply to Geerling and Loewy Am J Physiol Renal Physiol, July 1, 2007; 293(1): F442 - F443. [Full Text] [PDF]
|
|